iRhythm Holdings, Inc. Financing Cash Flow
iRhythm Holdings, Inc. (IRTC) reported Financing Cash Flow of $4.23 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- iRhythm Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $4.08M, a 42.49% decline year-over-year.
- iRhythm Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $149.00K, a 91.38% decline year-over-year.
- iRhythm Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $2.96M, a 0.94% decline year-over-year.
- iRhythm Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $825.00K.
- iRhythm Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $12.61M, a 97.53% decline from fiscal 2024.
- iRhythm Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $511.38M, a 5697.97% increase from fiscal 2023.
- iRhythm Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $8.82M, a 66.99% decline from fiscal 2022.
- iRhythm Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $26.72M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.23M 10-Q · filed 2026-08-06 | $7.19M derived: sum of 3 quarters · filed 2026-08-06 | $8.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $149.00K 10-Q · filed 2026-04-30 | $3.11M derived: sum of 2 quarters · filed 2026-04-30 | $3.93M derived: sum of 3 quarters · filed 2026-04-30 | $11.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.78M derived: sum of 2 quarters · filed 2026-02-19 | $10.88M derived: sum of 3 quarters · filed 2026-08-06 | $12.61M 10-K · filed 2026-02-19 |
| 2025-09-30 | $825.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $7.92M derived: sum of 2 quarters · filed 2026-08-06 | $9.65M 10-Q · filed 2025-10-30 | $12.63M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $7.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $8.82M 10-Q · filed 2026-08-06 | $11.81M derived: sum of 3 quarters · filed 2026-08-06 | $11.78M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.73M 10-Q · filed 2026-04-30 | $4.72M derived: sum of 2 quarters · filed 2026-04-30 | $4.68M derived: sum of 3 quarters · filed 2026-04-30 | $8.47M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.95M derived: sum of 2 quarters · filed 2026-02-19 | $6.74M derived: sum of 3 quarters · filed 2026-02-19 | $511.38M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.75M derived: sum of 2 quarters · filed 2025-10-30 | $508.39M 10-Q · filed 2025-10-30 | $511.86M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $3.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $508.43M 10-Q · filed 2025-07-31 | $511.90M derived: sum of 3 quarters · filed 2026-02-19 | $511.96M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $504.64M 10-Q · filed 2025-05-01 | $508.11M derived: sum of 2 quarters · filed 2026-02-19 | $508.18M derived: sum of 3 quarters · filed 2026-02-19 | $512.56M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.53M derived: sum of 2 quarters · filed 2026-02-19 | $7.92M derived: sum of 3 quarters · filed 2026-02-19 | $8.82M 10-K · filed 2026-02-19 |
| 2023-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $4.45M derived: sum of 2 quarters · filed 2024-10-30 | $5.35M 10-Q · filed 2024-10-30 | $8.50M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $4.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $5.29M 10-Q · filed 2024-08-01 | $8.43M derived: sum of 3 quarters · filed 2025-02-20 | $10.10M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $905.00K 10-Q · filed 2024-05-02 | $4.05M derived: sum of 2 quarters · filed 2025-02-20 | $5.71M derived: sum of 3 quarters · filed 2025-02-20 | $12.98M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $4.81M derived: sum of 2 quarters · filed 2025-02-20 | $12.08M derived: sum of 3 quarters · filed 2025-02-20 | $26.72M 10-K · filed 2025-02-20 |
| 2022-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $8.93M derived: sum of 2 quarters · filed 2023-11-02 | $23.57M 10-Q · filed 2023-11-02 | $23.94M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $7.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $21.91M 10-Q · filed 2023-08-04 | $22.27M derived: sum of 3 quarters · filed 2024-02-22 | $19.44M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $14.64M 10-Q · filed 2023-05-04 | $15.01M derived: sum of 2 quarters · filed 2024-02-22 | $12.17M derived: sum of 3 quarters · filed 2024-02-22 | $12.51M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$2.47M derived: sum of 2 quarters · filed 2024-02-22 | -$2.13M derived: sum of 3 quarters · filed 2024-02-22 | -$28.58M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$2.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$2.50M derived: sum of 2 quarters · filed 2022-11-04 | -$28.95M 10-Q · filed 2022-11-04 | -$25.99M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $338.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$26.11M 10-Q · filed 2022-08-05 | -$23.15M derived: sum of 3 quarters · filed 2023-02-23 | $184.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$26.45M 10-Q · filed 2022-05-06 | -$23.49M derived: sum of 2 quarters · filed 2023-02-23 | $183.66M derived: sum of 3 quarters · filed 2023-02-23 | $189.36M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $210.10M derived: sum of 2 quarters · filed 2023-02-23 | $215.81M derived: sum of 3 quarters · filed 2023-02-23 | $214.32M 10-K · filed 2023-02-23 |
| 2020-09-30 | $207.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $212.85M derived: sum of 2 quarters · filed 2021-11-05 | $211.36M 10-Q · filed 2021-11-05 | $214.55M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $5.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $4.21M 10-Q · filed 2021-08-09 | $7.41M derived: sum of 3 quarters · filed 2022-02-28 | $113.98M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$1.49M 10-Q · filed 2021-05-10 | $1.70M derived: sum of 2 quarters · filed 2022-02-28 | $108.28M derived: sum of 3 quarters · filed 2022-02-28 | $111.22M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $109.77M derived: sum of 2 quarters · filed 2022-02-28 | $112.71M derived: sum of 3 quarters · filed 2022-02-28 | $111.58M 10-K · filed 2022-02-28 |
| 2019-09-30 | $106.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $109.52M derived: sum of 2 quarters · filed 2020-11-06 | $108.38M 10-Q · filed 2020-11-06 | $111.14M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $2.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $1.81M 10-Q · filed 2020-08-07 | $4.56M derived: sum of 3 quarters · filed 2021-02-26 | $6.08M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$1.14M 10-Q · filed 2020-05-08 | $1.62M derived: sum of 2 quarters · filed 2021-02-26 | $3.13M derived: sum of 3 quarters · filed 2021-02-26 | $5.56M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $4.27M derived: sum of 2 quarters · filed 2021-02-26 | $6.70M derived: sum of 3 quarters · filed 2021-02-26 | $6.30M 10-K · filed 2021-02-26 |
| 2018-09-30 | $1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-12-23 | $3.94M derived: sum of 2 quarters · filed 2019-12-23 | $3.55M 10-Q · filed 2019-12-23 | $5.98M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $2.03M 10-Q · filed 2019-08-06 | $4.47M derived: sum of 3 quarters · filed 2020-03-02 | $6.20M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$397.00K 10-Q · filed 2019-05-10 | $2.04M derived: sum of 2 quarters · filed 2020-03-02 | $3.77M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2017-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $4.17M derived: sum of 2 quarters · filed 2020-03-02 | $6.53M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $4.09M 10-Q · filed 2018-10-30 | ||
| 2017-06-30 | $2.36M 10-Q · filed 2018-08-03 | |||
| 2016-12-31 | $111.25M 10-K · filed 2019-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |